James L

China Pharma: Explosive Growth at a Low Multiple

This stock had been on a tear but it should be noted also that the stock seems to have trouble keeping its momentum going, such as after its pretty good earnings report in August. Much of the recent momentum may be related to the momentum of several other momentum stocks as well. See the discussion on momentum stocks in chinesestocks-investch... I think the telling period on the value of this stock will be between now and November when the company releases its next report.